Dr. Deepika Kancherla, MD

Dr. Kancherla practices at Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente.

Dr. Kancherla's NPI, 1790963726, was assigned on January 31, 2008. Dr. Kancherla graduated from Siddhartha Medical College NTR in 2004. Dr. Kancherla holds California license A102562.

Dr. Kancherla's primary practice is Kaiser Permanente South San Francisco Medical Center, at 1200 El Camino Real, South San Francisco, CA 94080 in San Mateo County. The practice phone is (650) 742-3200.

Dr. Kancherla's primary practice is Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente. Dr. Kancherla is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is John Muir Health. Dmand AI also links Dr. Kancherla to 3 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kancherla practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kancherla's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kancherla is board certified in nephrology by the American Board of Internal Medicine. Dr. Kancherla is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and parathyroid gland disorder among the conditions Dr. Kancherla treats.

CMS data shows 1,242 Medicare services from Dr. Kancherla across 8 procedure codes in 2024, for 353 Medicare patients. Medicare paid $148,362 for them.

CMS counts 353 Medicare patients who saw Dr. Kancherla in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kancherla's median patient age at 74, with 43% women.

In 2024, Dr. Kancherla wrote 280 Medicare Part D claims for 90 patients. 92% of them were for generic drugs. CMS names the drug for 165 of them, across 9 drugs with 11 or more claims each, at $4,410 in total drug cost. In 2023, CMS named 270 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Kancherla for performance year 2024, reported as part of a group. Dr. Kancherla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kancherla as offering telehealth.

Dmand AI links 1 paper to Dr. Kancherla in 2014. Dr. Kancherla's most frequent co-authors are Stanley Jordan, MD, Joseph Michel Kahwaji, MD and Reiad Y. Najjar, MD.

CMS Open Payments shows 37 general payments to Dr. Kancherla from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 91% of the total. AstraZeneca Pharmaceuticals LP paid the most, $121.

Dr. Kancherla graduated from Siddhartha Medical College NTR in 2004.

Dr. Kancherla is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.